Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
Rapid Micro Biosystems Q1 Earnings Call Highlights
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026
What Makes Rapid Micro Biosystems (RPID) a New Buy Stock
Rapid Micro Biosystems Q4 Earnings Call Highlights
Rapid Micro Biosystems: Big Pharma Adoption Driving Growth
Rapid Micro Biosystems, Inc. (RPID) Q4 2025 Earnings Call Transcript
Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform
Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum
Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
Rapid Micro Biosystems (NASDAQ:RPID) COO Sells $21,179.76 in Stock
Rapid Micro Biosystems (NASDAQ:RPID) CFO Sells $67,635.68 in Stock
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Rapid Micro Biosystems, Inc. (RPID) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference
Reviewing Advanced Biomedical Technologies (OTCMKTS:ABMT) and Rapid Micro Biosystems (NASDAQ:RPID)
Rapid Micro Biosystems, Inc. (RPID) Q3 2025 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Misses Revenue Estimates
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
Rapid Micro Biosystems (RPID) to Release Earnings on Friday
Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference
Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025
Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) Q2 2025 Earnings Call Transcript
Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025
Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025